Contact us  Chinese
Shanghai Newsummit Biopharma Co.Ltd
business solutions
core business

Core Business Model

Key Products

core competitive advantages


Core Competitive Advantages
& Industry Status


Newsummit CRO Service Network

news

Warm Congratulations to Wuhan Biolake New Drug Incubation Public Service Platform being Recognized as a National Incubator

On Dec 10th, 2014, Ministry of Science (Guokefahuo [2014] No. 364) published the ‘Notice about certifying Beijing Houde Science and Technology Incubator Co., Ltd and other 104 companies to the status of National Incubator in Science and Technology’. Wuhan Biolake New Drug Incubation Public Service Platform ranked first in Hubei Province, and was officially recognized as a National Incubator.

Wuhan Biolake New Drug Incubation Public Service Platform was established in July, 2009. As one of the six support platforms within Biolake, New Drug Incubation has been focusing on the field of biomedicine, with incubator services rooted in new drug research and drug registration. It aims to provide incubated companies with installation service, project grant application support, new drug research and implementation, drug registration and consulting, legal and financial services, investment and financing services, human resources training etc. at the highest quality level.

Being certified as national incubator this time was a sense of recognition of tangible results for our previous work, and our platform will continue to improve its service functions, enhance service initiative and performance, improve professional level, make persistent efforts to provide better service for incubated companies, and make full use of the status of National Incubator in Science and Technology.

 

Copyright(C)2016,Shanghai Newsummit Biopharma Co.Ltd All Rights Reserved.  Supported by Information Center